LASTACAFT
These highlights do not include all the information needed to use LASTACAFT safely and effectively. See full prescribing information for LASTACAFT. LASTACAFT (alcaftadine ophthalmic solution) 0.25%Initial U.S. Approval: 2010
4b8c6afe-2d76-46c7-a23e-99db5e180ff6
HUMAN PRESCRIPTION DRUG LABEL
Sep 5, 2012
Rebel Distributors Corp
DUNS: 118802834
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
alcaftadine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (8)
Drug Labeling Information
INDICATIONS & USAGE SECTION
1 INDICATIONS AND USAGE
LASTACAFT**®** is an H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis.
LASTACAFT**®** is an H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. (1)
CONTRAINDICATIONS SECTION
4 CONTRAINDICATIONS
None.
DOSAGE FORMS & STRENGTHS SECTION
3 DOSAGE FORMS AND STRENGTHS
Topical ophthalmic solution containing alcaftadine, 0.25% (2.5 mg/mL).
Ophthalmic solution containing alcaftadine, 0.25% (2.5 mg/mL) (3)